DelveInsight’s Gastroesophageal Reflux Disease (GERD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Gastroesophageal Reflux Disease (GERD) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Gastroesophageal Reflux Disease (GERD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Gastroesophageal Reflux Disease (GERD) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Gastroesophageal Reflux Disease (GERD) market.
• Identifying patient populations in the global “Gastroesophageal Reflux Disease (GERD)market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Gastroesophageal Reflux Disease (GERD) therapeutics in each of the markets covered.
• To understand the future market competition in the global Gastroesophageal Reflux Disease (GERD) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Gastroesophageal Reflux Disease (GERD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
Note: This report requires 7-10 business days to complete.
'
Table of Contents
• Gastroesophageal Reflux Disease (GERD) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Gastroesophageal Reflux Disease (GERD) Market
• Global Epidemiology of Gastroesophageal Reflux Disease (GERD) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Gastroesophageal Reflux Disease (GERD) Drug Sales (USD Millions)
• Table 6: Global Epidemiology of Gastroesophageal Reflux Disease (GERD)(2013-2023)
• Table 7: Gastroesophageal Reflux Disease (GERD) Global Market (USD Millions), (2013-2015)
• Table 8: Gastroesophageal Reflux Disease (GERD) Global Market (USD Millions), (2016-2023)
• Table 9: Gastroesophageal Reflux Disease (GERD) US Market (USD Millions), (2013-2015)
• Table 10: Gastroesophageal Reflux Disease (GERD) US Market (USD Millions), (2016-2023)
• Table 11: Gastroesophageal Reflux Disease (GERD) Germany Market (USD Millions), (2013-2015)
• Table 12: Gastroesophageal Reflux Disease (GERD) Germany Market (USD Millions), (2016-2023)
• Table 13: Gastroesophageal Reflux Disease (GERD) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Gastroesophageal Reflux Disease (GERD) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Gastroesophageal Reflux Disease (GERD) France Market (USD Millions), (2013-2015)
• Table 16: Gastroesophageal Reflux Disease (GERD) France Market (USD Millions), (2016-2023)
• Table 17: Gastroesophageal Reflux Disease (GERD) Italy Market (USD Millions), (2013-2015)
• Table 18: Gastroesophageal Reflux Disease (GERD) Italy Market (USD Millions), (2016-2023)
• Table 19: Gastroesophageal Reflux Disease (GERD) Spain Market (USD Millions), (2013-2015)
• Table 20: Gastroesophageal Reflux Disease (GERD) Spain Market (USD Millions), (2016-2023)
• Table 21: Gastroesophageal Reflux Disease (GERD) Japan Market (USD Millions), (2013-2015)
• Table 22: Gastroesophageal Reflux Disease (GERD) Japan Market (USD Millions), (2016-2023)
• Table 23: Gastroesophageal Reflux Disease (GERD) ROW Market (USD Millions), (2013-2015)
• Table 24: Gastroesophageal Reflux Disease (GERD) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Gastroesophageal Reflux Disease (GERD) Drug Sales (USD Millions)
• Figure 2: Global Epidemiology of Gastroesophageal Reflux Disease (GERD) (2013-2023)
• Figure 3: Gastroesophageal Reflux Disease (GERD) Global Market (USD Millions), (2013-2015)
• Figure 4: Gastroesophageal Reflux Disease (GERD) Global Market (USD Millions), (2016-2023)
• Figure 5: Gastroesophageal Reflux Disease (GERD) US Market (USD Millions), (2013-2015)
• Figure 6: Gastroesophageal Reflux Disease (GERD) US Market (USD Millions), (2016-2023)
• Figure 7: Gastroesophageal Reflux Disease (GERD) Germany Market (USD Millions), (2013-2015)
• Figure 8: Gastroesophageal Reflux Disease (GERD) Germany Market (USD Millions), (2016-2023)
• Figure 9: Gastroesophageal Reflux Disease (GERD) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Gastroesophageal Reflux Disease (GERD) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Gastroesophageal Reflux Disease (GERD) France Market (USD Millions), (2013-2015)
• Figure 12: Gastroesophageal Reflux Disease (GERD) France Market (USD Millions), (2016-2023)
• Figure 13: Gastroesophageal Reflux Disease (GERD) Italy Market (USD Millions), (2013-2015)
• Figure 14: Gastroesophageal Reflux Disease (GERD) Italy Market (USD Millions), (2016-2023)
• Figure 15: Gastroesophageal Reflux Disease (GERD) Spain Market (USD Millions), (2013-2015)
• Figure 16: Gastroesophageal Reflux Disease (GERD) Spain Market (USD Millions), (2016-2023)
• Figure 17: Gastroesophageal Reflux Disease (GERD) Japan Market (USD Millions), (2013-2015)
• Figure 18: Gastroesophageal Reflux Disease (GERD) Japan Market (USD Millions), (2015-2023)
• Figure 19: Gastroesophageal Reflux Disease (GERD) ROW Market (USD Millions), (2013-2015)
• Figure 20: Gastroesophageal Reflux Disease (GERD) ROW Market (USD Millions), (2016-2023)
• AstraZeneca
• Dynogen Pharmaceuticals
• Pfizer
• Sucampo Pharmaceuticals
• Ironwood Pharmaceuticals
• Takeda Pharmaceutical Company Ltd.
• Novartis
• Eisai Co Ltd
• Dainippon Sumitomo Pharma
